EOS imaging announces CE mark of hipEOS

EOS imaging (Paris:EOSI) (NYSE Euronext, FR0011191766 - EOSI), the pioneer in orthopaedic 2D/3D imaging, announced today the CE mark of hipEOS, a 3D hip arthroplasty planning software based on EOS biplanar 3D imaging.

hipEOS is the first offering of a software portfolio to be associated with the EOS imaging system. It is based on EOS low dose 3D images and technology from OneFit Medical, a company EOS imaging acquired in late 2013. It will initially be deployed as an online service to assist surgeons in hip prosthesis selection and placement simulation based on 3D images generated by the EOS system.

Prof. Didier Mainard of Nancy University Hospital in France said, "hipEOS enables physicians and surgeons to select the best fit prosthesis for each patient using 2D and 3D images and the EOS imaging data set. The 3D element of the software takes a lot of the guesswork out of prosthesis sizing and should allow surgeons to perform these replacements more efficiently thanks to better visualization."

Marie Meynadier, CEO of EOS imaging, said, "The acquisition of OneFit and subsequent development of surgical planning software such as hipEOS allow us to associate to our unique imaging platform offerings with strong value for the surgical care pathways. The EOS system, with its 2D/3D capabilities, redefines a class for musculoskeletal imaging, and the addition of complementary software will further strengthen and extend this core offering. hipEOS is the first step towards the development of a comprehensive offering of dedicated, surgeon-centric software and hardware tools based on EOS' unique technology."

EOS imaging will exhibit at AAOS 2014, March 11-15 at the Morial Convention Center, Booth #2335.